

UCB’s Boston Research & Development Hub works on new platforms and projects across several disease areas. These R&D facilities span 94,000 square feet in Bedford and Cambridge, with more than 125 employees working in a variety of roles.

Our satellite location in downtown Durham focuses on understanding complex disease mechanism to potentially develop more impactful and better targeted therapies. This lab offers 5,000 square feet of research capability and is home to Element Genomics, which UCB acquired in 2018.

With over 13,000 square feet of lab space, our satellite in the Pacific Northwest focuses on discovering new medicines and groundbreaking therapies, structural biology, and molecular biology.

